Kaival Brands Expands Distribution for Bidi Vapor
Kaival Brands Innovations Group has announced an expansion in distribution expected to reach 28,000 additional stores for its BIDI® Stick products. This follows growing sales volumes and new wholesale accounts. Approximately 3,900 new store locations are anticipated to activate within 45 days, including significant orders exceeding $1.1 million from a major retailer. A recent judicial stay allowed Bidi Vapor to sell all flavored products while still in litigation against the FDA's marketing denial order, reinstating sales growth potential.
- Expansion expected to reach 28,000 additional stores.
- Projected activation of 3,900 new store locations in 45 days.
- Major retailer orders totaling over $1.1 million.
- Judicial stay allows continued sale of flavored BIDI® Sticks.
- None.
Distribution expected to reach 28,000 additional stores
GRANT, Fla., April 18, 2022 /PRNewswire/ -- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive global distributor of all products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), which are intended for adults 21 and over, today announced the expansion of additional wholesaler and retailer accounts, which, together, are expected to reach approximately 28,000 additional stores.
Niraj Patel, Chief Executive Officer of Kaival Brands said, "We are encouraged by growing sales volumes in our second fiscal quarter generated by both established wholesalers and retailers selling the BIDI® Stick in new stores, as well as new wholesale and retail accounts being added to our distribution network. We anticipate the activation of approximately 3,900 new store locations over the next 45 days, including one new major retailer having already placed orders totaling more than
This expansion represents a positive development for the Company since the U.S. Food and Drug Administration ("FDA") issued its marketing denial order ("MDO") to Bidi Vapor this past September, as it did for about
After the court granted Bidi Vapor the judicial stay of the MDO in February 2022, the Company is seeing indications of growing confidence in the vaping industry, with Bidi Vapor's flavored electronic nicotine delivery systems (ENDS) now declared legal to sell while pending resolution of the ongoing litigation.
"This was a significant event not only for Kaival Brands and Bidi Vapor, but the entire industry," said Patel of the court decision. "The judicial stay granted in February allowed us to resume sale of all 11 flavored products in the BIDI® Stick lineup. We are eager to return our flavored products to the shelves of retailers that comply with the Prevent All Cigarette Trafficking Act so adult consumers can enjoy their preferred flavors once again. As a result of the judicial stay, we expect revenues to resume an upward trajectory as renewed distribution ramps up and sales of flavored BIDI® Sticks increase."
Additionally, we believe that the FDA's new authority over products using synthetic nicotine will only bolster Kaival Brands' market position, as more retailers understand the nearly insurmountable compliance hurdles facing those manufacturers of non-compliant, synthetic products. The Company applauds the recent bi-partisan effort by Congress to give the FDA authority over synthetic nicotine. The Company, along with Bidi Vapor, prioritizes regulatory compliance to ensure high standards for product quality.
"Products in the vaping industry should be developed and placed in the market under a high degree of supervision, such as the FDA's PMTA process or the FDA's drug-approval process," continued Patel. "We anticipate that as the FDA begins enforcement against illegally marketed and synthetic-nicotine vaping products, there may be an increased demand for compliant and legal vaping products, such as the BIDI® Stick.
Adult smokers aged 21 and older who are looking for an alternative to combustible cigarettes have been our priority from the beginning," Patel said. "It hasn't been an easy road, but we fight to create a level playing field for our products and pave a realistic path for adult smokers to change their habits. This is and always has been our commitment."
ABOUT BIDI VAPOR
Based in Melbourne, Florida, Bidi Vapor maintains a commitment to responsible marketing, supporting age-verification standards and sustainability through its BIDI® Cares recycling program. Bidi Vapor's premier device, the BIDI® Stick, is a premium product made with medical-grade components, a UL-certified battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. Bidi Vapor is also adamant about strict compliance with all federal, state and local guidelines and regulations. At Bidi Vapor, innovation is key to its mission, with the BIDI® Stick promoting environmental sustainability, while providing a unique vaping experience to adult smokers.
For more information, visit www.bidivapor.com
ABOUT KAIVAL BRANDS
Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Our vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor.
Learn more about Kaival Brands Innovations Group, Inc., at https://ir.kaivalbrands.com
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements" within the meaning of federal securities laws, which are statements other than historical facts that frequently use words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "position," "should," "strategy," "target," "will," and similar words. All forward-looking statements speak only as of the date of this press release. Although we believe that the plans, intentions, and expectations reflected in or suggested by the forward-looking statements are reasonable, there is no assurance that these plans, intentions, or expectations will be achieved. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such statements. Our business may be influenced by many factors that are difficult to predict, involve uncertainties that may materially affect results, and are often beyond our control. Factors that could cause or contribute to such differences include, but are not limited to, the timing and results of Bidi Vapor's appeal of the FDA's PMTA determinations; the scope of future FDA enforcement of regulations in the ENDS industry; the FDA's approach to the regulation of synthetic nicotine and its impact on our business; the duration and scope of the COVID-19 pandemic and impact on the demand for the products we distribute; the actions governments, businesses, and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic and actions taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the effects of steps that we could take to reduce operating costs; our inability to generate and sustain profitable sales growth; circumstances or developments that may make us unable to implement or realize anticipated benefits, or that may increase the costs, of our current and planned business initiatives; changes in government regulation or laws that affect our business; significant changes in our relationships with our distributors or sub-distributors; and those factors detailed by us in our public filings with the Securities and Exchange Commission. All forward-looking statements included in this press release are expressly qualified in their entirety by such cautionary statements. Except as required under the federal securities laws and the Securities and Exchange Commission's rules and regulations, we do not have any intention or obligation to update any forward-looking statements publicly, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kaival-brands-expands-distribution-for-bidi-vapor-301526896.html
SOURCE Kaival Brands
FAQ
What is the significance of Kaival Brands expanding distribution for KAVL?
How many new store locations will Kaival Brands activate in relation to KAVL?
What are the recent developments regarding KAVL and the FDA's marketing denial order?
What are the projected sales implications for KAVL's products?
What is the potential market impact of the FDA's new authority over synthetic nicotine for KAVL?
